Archive for the ‘News’ Category

FDA to Review Hologic 3D Digital Mammography
FDA to Review Hologic 3D Digital Mammography
Hologic has lately made an announcement that its Selenia Dimensions three dimensional mammography tomosynthesis system would be reassessed by the FDA. The piece of equipment is capable of taking several low-energy X-ray images from varying viewpoints and reconstructing a three-dimensional (3D) imagery of the breast. Hologic’s device is obtainable in major areas across the globe, however the Radiological Devices Panel of the FDA is due to convene in September for discussing the system. Hologic’s white paper has explained in detail regarding breast tomosynthesis that involves the following steps: Breast compression in a benchmark manner and with the breast held in a fixed position, X-ray tube rotation is done above a restricted angular scope. A sequence of less dosage exposures are done  [...]

August 2nd, 2010 | Breast Cancer, News
‘ExacTrac’ Tumor Motion Monitoring : Enhanced Respiration-Triggered Radiotherapy
‘ExacTrac’ Tumor Motion Monitoring : Enhanced Respiration-Triggered Radiotherapy
ExacTrac Infrared Monitoring device is the exciting new innovation by BrainLAB which is an adjunct tool to existent therapy machines to monitor patient positions during radiation therapy sessions. CBCT (Cone Beam CT) is the commonly employed device in several cancer care facilities for patient set-up; but is incapable of tracking the patient’s positioning alterations which could take place at the time of radiotherapy. The ExacTrac Infrared Monitoring device could be mounted on the ceiling and helps in tracking a patient’s positions all through therapy delivery thus offering doctors greater self-confidence for targeted radiation therapy. An infinitesimal budge from the preliminary patient set-up could have a damaging effect on healthy tissues adjoining the tumor. The ExacTrac technology  [...]

August 1st, 2010 | News, Tests And Procedures
LITT Nanoparticle Technology – New Cancer Treatment Shows Promise
LITT Nanoparticle Technology – New Cancer Treatment Shows Promise
A group of investigators at the Wake Forest Univ. Baptist Medical Center lately made an announcement that they have made noteworthy improvement in an investigational cancer treatment called LITT (laser-induced thermal therapy). The LITT treatment involves introduction of nanoparticles to the region surrounding the tumor after which laser treatment is employed for heating these nanoparticles and destroying the cancer-ridden tissues. Study investigators from Wake Forest fine-tuned the therapy by employing iron-comprising MWCNTs (multi-walled carbon nanotubes – strands of hollow carbon which are ten thousand fold finer in comparison to a hair in humans) that could be traced inside the body of a patient via the usage of Magnetic resonance imaging (MRI), thus facilitating improved precision delivery  [...]

July 26th, 2010 | News
IMAT Treatment – Beneficial Technology for Paediatric Brain Cancer
IMAT Treatment – Beneficial Technology for Paediatric Brain Cancer
A research presentation put forth during the fifty-second yearly conference of AAPM (Association of Physicists in Medicine) shows that kids with brain cancer undergoing radiation therapy (X-ray beams focused for killing malignant cells and shrivelling tumors) might be benefited by a technology termed as ‘IMAT’ or intensity modulated arc therapy. Intensity modulated arc therapy method is reliant on novel attributes of the newest generation of X-ray treatment device which provide X ray sources in continually rotating varied directions encircling the patient at the time of therapy. This technique helps to increase directions from which the X-ray beams are coming from. The research that was carried out by physical scientists from the St. Jude Children’s Hospital located in Memphis Tennessee  [...]

July 21st, 2010 | Brain Cancer, News
Nun’s Syndrome and Breast Cancer Epidemic
Nun’s Syndrome and Breast Cancer Epidemic
Annual sky-rocketing breast cancer cases continue to be a matter of grave concern in spite of periodical declarations of promising novel drugs and therapies. Just ten years back, a female’s lifetime risk of getting breast cancer was 1in twelve, however currently it has become 1 in 9. Particularly bothersome are Britain’s statistics wherein breast cancer constitutes one-third of female’s cancers and afflicted over forty-seven thousand females during 2007. Even though wide-ranging breast cancer causes exist, but it has become apparent that current lifestyles that women has adopted is accountable. The most hyped exemplar is Kylie Minogue being identified with breast cancer in thirty-six. New-fangled studies in the United States have shown that breast tumors are arising (6 years sooner) among  [...]

July 19th, 2010 | Breast Cancer, News
Abortion Procedure linked to three-fold augmented Breast Cancer Risk
Abortion Procedure linked to three-fold augmented Breast Cancer Risk
An abortion procedure could treble a female’s chances of imminently getting breast cancer, according to study investigators. A group of researchers have claimed this startling outcome following an in-depth study that probes how mothers who breastfeed are shielded from developing breast cancer. As the study team drew to a conclusion that nursing provides noteworthy shielding from cancer, they additionally cited that the peak cited risk aspects in getting breast cancer was termination of pregnancy or the abortion procedure. Other breast cancer risk factors include the inception of menopause and those women who smoke. The study outcomes printed in the journal ‘Cancer Epidemiology’, are the most up-to-date trial that finds an association in-between breast cancer and the abortion procedure. The  [...]

June 30th, 2010 | Breast Cancer, News
New-Fangled Drug Combo Effectual Against Pancreas Cancer – Broccoli Emerges as Cancer Combater
New-Fangled Drug Combo Effectual Against Pancreas Cancer – Broccoli Emerges as Cancer Combater
The novel cancer drug sorafenib shows potential. Sorafenib is employed for treatment of later staging cancers of kidney and liver and is additionally effective in pancreas cancer by tackling tumor stem cells. A research group headed by Prof. Ingrid Herr, HOD, Molecular Oncosurgery, Heidelberg Univ. Hospital in collaboration with the German Cancer Research Center, evaluated the novel substance in rodent and pancreatic cancer cells. It hampered resistance-exhibiting cancer stem cells and was additionally effectual when merged with sulforaphene, an organic constituent present in broccoli. Annually, pancreatic cancer develops in around 12900 Germans and is often spotted quite later on thus leading to fewer individuals surviving the analysis more than a year’s time. Particularly, early harbinger  [...]

June 28th, 2010 | News, Pancreatic Cancer
Risk of Brain Tumor Development Five-Fold Among Mobile Phone Users
Risk of Brain Tumor Development Five-Fold Among Mobile Phone Users
Mobile phone users have a fivefold greater likelihood of developing brain tumors as compared to people using land lines, researchers have cautioned. Researchers have stated that several earlier studies probing cell phone safety considerably undervalued the risk of cancer developing and that brain tumor formation is commonly found on that side of a person’s head where the cell phone had been held against as compared to the other side. Following re-analysis of previous researches, the study authors reached a conclusion that risk of developing such tumors would lay in-between ten to five hundred percent more with protracted cell phone usage. Helming the study, Lloyd Morgan cautioned that the study outcomes elevated the likelihood of a brain tumor epidemic until individuals alter their patterns  [...]

June 23rd, 2010 | Cancer Education, News
Cutting-Edge, Life-Saving Cancer Research Advancements
Cutting-Edge, Life-Saving Cancer Research Advancements
Elucidated herewith are several enthralling cancer research advancements noted in several areas that could help transform this eradicator into a chronic disease. Breast Cancer There are several on-going studies on a vaccination which could avert breast cancer beginning the subsequent year. The shot is intended to target alpha lactalbumin protein that is present in breast tumors. The brainchild behind this vaccine, Dr. Vincent Tuohy deems that it could halt seventy percent of cancers. He even draws parallels between tumors and drunkards in bars who say and do inappropriate things like alpha lactalbumin expression which is targeted by this vaccine. Bowel Cancer A novel 5 minute test is slated to lower chances of developing bowel cancer by one-third and salvage scores of lives. The Flexi-Scope  [...]

June 18th, 2010 | Cancer Education, News
Thyroid Cancer Risk Rises Five Folds with Ten Dental X-Rays
Thyroid Cancer Risk Rises Five Folds with Ten Dental X-Rays
Study researchers have cautioned that getting an annual dental X-ray might drastically augment risk of developing thyroid cancer. Investigators observed that people who were given dental X-rays a minimum of 10 times had a five folds greater likelihood of developing thyroid cancer. On the basis of this study finding, scientists have raised caveat that X-rays must not be offered during check-up or when a new patient is being registered, in spite of such a practice being prevalent in several dental surgery procedures. As the number of thyroid cancer cases has doubled in the last three decades, researchers state that the likely threats associated with dental X-ray have mostly been ignored. Study investigator Dr. Anjum Memon stated that their research has highlighted that similar to the trunk or  [...]

June 9th, 2010 | News, Thyroid Cancer
Monumental Vaccine for Breast Cancer Prevention could be on Trial in a Year’s Time
Monumental Vaccine for Breast Cancer Prevention could be on Trial in a Year’s Time
A pioneering shot for Breast cancer prevention and treatment has been created. The drug is due to go on trial as soon as the upcoming year’s time and might obliterate nearly seventy percent of breast cancers and salvage over eight thousand lives annually in just the United Kingdom. The brain child behind this revolutionary vaccine, Dr. Vincent Tuohy stated that the results could be colossal. He further stated that this shot would in the near future be employed for breast cancer prevention among adult females in the analogous manner that the shots have been capable of preventing infancy illness. Dr. Tuohy further mentioned that he was hopeful about the shot soon being employed for also targeting other kinds of cancers. The drug has been found to target a protein known as alphalactalbumin which  [...]

June 4th, 2010 | Breast Cancer, News
New Streamlined Ovarian Cancer Diagnosis using ROCA Model
New Streamlined Ovarian Cancer Diagnosis using ROCA Model
Early testing indicates that a new-fangled screening strategy has shown potential in enhancing ovarian cancer diagnosis among females in their post-menopause phase who are at an average risk of developing the disease. The approach employs a mathematical model merging variations in blood levels of CA-125 protein and age of the woman over periods of time for estimating risk of developing ovarian cancer. Study investigator, Dr. Karen Lu stated that during the study conducted on over 3200 females in their post-menopause phase, the strategy proved viable with hardy any false positive outcomes. Dr. Lu taking a cautious stand stated that there have been several other strategies that appeared to show potential in preliminary tests have eventually emerged to be bogus starts. On the lookout for a Screening  [...]

May 26th, 2010 | News